Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F91YT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $218,873
Award facts
- Contract value 100% obligated
- $218,873.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $218,873.06 for Zepbound 5 mg/0.5 ml pen injections on January 27, 2026, with completion scheduled for January 28, 2026. This firm fixed-price, competitively awarded contract (no set-aside used) is performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates substantial capability in fulfilling government contracts across diverse therapeutic domains, with this Zepbound order exemplifying its role in supplying specialty pharmaceutical products to the Defense Health Agency and other federal healthcare systems. The broader IDC vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and various medical supplies, positioning AmerisourceBergen as a key logistics partner for the Department of Defense's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F91YT?
SPE2DR26F91YT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F91YT worth?
The government has obligated $218,873 on SPE2DR26F91YT.
Is contract SPE2DR26F91YT an order under another contract?
Yes. SPE2DR26F91YT is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91YT competed?
The extent of competition for SPE2DR26F91YT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award